The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 7
  • 1
    Gilham, Ian David, Dr
    Chairman born in March 1960
    Individual (5 offsprings)
    Officer
    2023-02-20 ~ now
    OF - director → CIF 0
  • 2
    Callaghan, Anastasia Jane, Dr
    Director born in November 1974
    Individual (1 offspring)
    Officer
    2022-07-15 ~ now
    OF - director → CIF 0
    Dr Anastasia Jane Callaghan
    Born in November 1974
    Individual (1 offspring)
    Person with significant control
    2022-07-15 ~ now
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
  • 3
    Sheppard, David William, Dr
    Non-Executive Director born in March 1974
    Individual (3 offsprings)
    Officer
    2023-04-05 ~ now
    OF - director → CIF 0
  • 4
    White, Mary Anne Louise
    Chief Finance Officer born in March 1972
    Individual (5 offsprings)
    Officer
    2025-01-09 ~ now
    OF - director → CIF 0
  • 5
    Mellad, Jason Alexander, Dr
    Director born in March 1982
    Individual (11 offsprings)
    Officer
    2022-10-17 ~ now
    OF - director → CIF 0
  • 6
    Henderson, Charlotte Anne, Dr
    Director born in February 1985
    Individual (1 offspring)
    Officer
    2022-07-15 ~ now
    OF - director → CIF 0
    Dr Charlotte Anne Henderson
    Born in February 1985
    Individual (1 offspring)
    Person with significant control
    2022-07-15 ~ now
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
  • 7
    University House, Winston Churchill Avenue, Portsmouth, United Kingdom
    Corporate (1 offspring)
    Person with significant control
    2022-09-30 ~ now
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
Ceased 1
parent relation
Company in focus

REVONA BIO LTD

Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Property, Plant & Equipment
14,480 GBP2024-09-30
3,687 GBP2023-09-30
Debtors
150,629 GBP2024-09-30
93,013 GBP2023-09-30
Cash at bank and in hand
470,048 GBP2024-09-30
64,823 GBP2023-09-30
Current Assets
620,677 GBP2024-09-30
157,836 GBP2023-09-30
Creditors
Current, Amounts falling due within one year
-7,157 GBP2024-09-30
-14,202 GBP2023-09-30
Net Current Assets/Liabilities
613,520 GBP2024-09-30
143,634 GBP2023-09-30
Total Assets Less Current Liabilities
628,000 GBP2024-09-30
147,321 GBP2023-09-30
Creditors
Non-current, Amounts falling due after one year
-959,710 GBP2024-09-30
-250,000 GBP2023-09-30
Net Assets/Liabilities
-331,710 GBP2024-09-30
-102,679 GBP2023-09-30
Equity
Called up share capital
2 GBP2024-09-30
2 GBP2023-09-30
0 GBP2022-07-14
Retained earnings (accumulated losses)
-331,712 GBP2024-09-30
-102,681 GBP2023-09-30
0 GBP2022-07-14
Equity
-331,710 GBP2024-09-30
-102,679 GBP2023-09-30
Profit/Loss
Retained earnings (accumulated losses)
-229,031 GBP2023-10-01 ~ 2024-09-30
-102,681 GBP2022-07-15 ~ 2023-09-30
Profit/Loss
-229,031 GBP2023-10-01 ~ 2024-09-30
-102,681 GBP2022-07-15 ~ 2023-09-30
Issue of Equity Instruments
Called up share capital
2 GBP2022-07-15 ~ 2023-09-30
Issue of Equity Instruments
2 GBP2022-07-15 ~ 2023-09-30
Average Number of Employees
72023-10-01 ~ 2024-09-30
42022-07-15 ~ 2023-09-30
Director Remuneration
102,558 GBP2023-10-01 ~ 2024-09-30
69,245 GBP2022-07-15 ~ 2023-09-30
Property, Plant & Equipment - Gross Cost
Other
18,350 GBP2024-09-30
4,628 GBP2023-09-30
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Other
3,870 GBP2024-09-30
941 GBP2023-09-30
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Other
2,929 GBP2023-10-01 ~ 2024-09-30
Property, Plant & Equipment
Other
14,480 GBP2024-09-30
3,687 GBP2023-09-30
Amount of corporation tax that is recoverable
Current
55,959 GBP2024-09-30
24,119 GBP2023-09-30
Other Debtors
Amounts falling due within one year
94,670 GBP2024-09-30
68,894 GBP2023-09-30
Debtors
Current, Amounts falling due within one year
150,629 GBP2024-09-30
93,013 GBP2023-09-30
Trade Creditors/Trade Payables
Current
719 GBP2024-09-30
10,126 GBP2023-09-30
Other Creditors
Current
6,438 GBP2024-09-30
4,076 GBP2023-09-30
Creditors
Current
7,157 GBP2024-09-30
14,202 GBP2023-09-30
Other Creditors
Non-current
959,710 GBP2024-09-30
250,000 GBP2023-09-30
  • REVONA BIO LTD
    Info
    Registered number 14236436
    34 High Street, Aldridge, Walsall, West Midlands WS9 8LZ
    Private Limited Company incorporated on 2022-07-15 (2 years 10 months). The company status is Active.
    The last date of confirmation statement was made at 2024-07-14
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

qrcode

Privacy policy

© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.